Showing results (861-870 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|August 21, 2022
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort studySeran Hakki, Jie Zhou, Jakob Jonnerby, et al.
The Lancet. Respiratory Medicine|August 19, 2022
Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future researchNeal L Benowitz, Maciej L Goniewicz, Bonnie Halpern-Felsher, et al.
The Lancet. Respiratory Medicine|April 30, 2021
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into contextFederico Angriman, Bruno L Ferreyro, Lisa Burry, et al.
The Lancet. Respiratory Medicine|May 7, 2021
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational studyAlison J Dicker, Mike Lonergan, Holly R Keir, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
The Lancet. Respiratory Medicine|May 5, 2015
Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findingsLaurel K Willig, Josh E Petrikin, Laurie D Smith, et al.
The Lancet. Respiratory Medicine|May 19, 2020
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapyPeter M George, Athol U Wells, R Gisli Jenkins
The Lancet. Respiratory Medicine|May 19, 2020
Tracheostomy in the COVID-19 era: global and multidisciplinary guidanceBrendan A McGrath, Michael J Brenner, Stephen J Warrillow, et al.
The Lancet. Respiratory Medicine|June 2, 2020
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trialYi-Long Wu, Ying Cheng, Jianying Zhou, et al.
The Lancet. Respiratory Medicine|June 23, 2020
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort studyAnna Coppo, Giacomo Bellani, Dario Winterton, et al.
Pageof 104